Combination of escitalopram and a 5-HT1A receptor antagonist selectively decreases the extracellular levels of dopamine in the nucleus accumbens relative to striatum through 5-HT2C receptor stimulation; suggestive of antipsychotic potential-Reference-Cited by-同舟云学术

Combination of escitalopram and a 5-HT1A receptor antagonist selectively decreases the extracellular levels of dopamine in the nucleus accumbens relative to striatum through 5-HT2C receptor stimulation; suggestive of antipsychotic potential

Published:2011-01 Issue:3 Volume:97 Page:479-485
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Hovelsø Nanna,Sager Thomas Nicolaj,Mørk Arne

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference55 articles.

1. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission;Alex;Pharmacol Ther,2007

2. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade;Arnt;Acta Pharmacol Toxicol,1982

3. Differentiation of classical and novel antipsychotics using animal models;Arnt;Int Clin Psychopharmacol,1997

4. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists;Artigas;Trends Neurosci,1996

5. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials;Ballesteros;J Affect Disord,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence;Progress in Brain Research;2021

2. Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α2-adrenoceptors in the rat hippocampus and dopamine levels in the nucleus accumbens;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2020-12

3. Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson’s Disease and Schizophrenia;Neuroscience;2020-07

4. Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications;Progress in Neurobiology;2017-04

5. Escitalopram affects spexin expression in the rat hypothalamus, hippocampus and striatum;Pharmacological Reports;2016-12